 Clinical measures will be performed at randomization, at 3 and 6 weeks and 9 weeks in the patients in the extension phase as well as at the follow up assessments. A trained rater who is blind to treatment type will administer all measures. Raters will be required to maintain 90 reliability on the primary outcome assessments on ratings with 6 monthly assessments based on videotaped interviews. 